Non-inferiority of GlaxoSmithKline Biologicals' influenza vaccine (GSK576389A) 1 container over 2 container presentation in adults aged 65 years and over.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2016
At a glance
- Drugs GSK 576389A (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 16 Oct 2008 Primary outcome added as reported by ClinicalTrials.gov.
- 12 Oct 2008 Actual number of patients (1596) added as reported by CT.gov
- 16 Nov 2007 Status changed from recruiting to completed.